Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/30796| Title: | Sex-related disparities in outcomes of cholangiocarcinoma patients in treatment trials. | Austin Authors: | Ledenko, Matthew;Antwi, Samuel O;Arima, Shiho;Driscoll, Julia;Furuse, Junji;Klümpen, Heinz-Josef;Larsen, Finn Ole;Lau, David K ;Maderer, Annett;Markussen, Alice;Moehler, Markus;Nooijen, Lynn E;Shaib, Walid L;Tebbutt, Niall C ;André, Thierry;Ueno, Makoto;Woodford, Rachel;Yoo, Changhoon;Zalupski, Mark M;Patel, Tushar | Affiliation: | National Health and Medical Research Council Clinical Trials Centre (NHMRC CTC), Medical Foundation Building, University of Sydney, Camperdown, NSW, Australia Department of Transplantation, Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, United States.. Olivia Newton-John Cancer Research Institute School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia Department of Medical Oncology, Olivia Newton-John Cancer Centre at Austin Health, Heidelberg, VIC, Australia Department of Quantitative Health Sciences, Mayo Clinic, Jacksonville, FL, United States.. Department of Digestive and Lifestyle Diseases, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.. Department of Transplantation, Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, United States.. Department of Medical Oncology, Kyorin University Faculty of Medicine, Tokyo, Japan.. Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Center (UMC), Amsterdam, Netherlands.. Department of Oncology, Copenhagen University Hospital, Herlev and Gentofte Hospital, Herlev, Denmark.. First Department of Medicine, University Medical Center of the Johannes-Gutenberg University, Mainz, Germany.. Research Center for Immunotherapy (FZI), University Medical Center, Johannes Gutenberg-University, Mainz, Germany.. Department of Oncology, Copenhagen University Hospital, Herlev and Gentofte Hospital, Herlev, Denmark.. First Department of Medicine, University Medical Center of the Johannes-Gutenberg University, Mainz, Germany.. Research Center for Immunotherapy (FZI), University Medical Center, Johannes Gutenberg-University, Mainz, Germany.. Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, Netherlands.. Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, United States.. Sorbonne University and Department of Medical Oncology, Hôpital Saint-Antoine, AP-HP, Paris, France.. Department of Gastroenterology, Hepatobiliary and Pancreatic Medical Oncology Division, Kanagawa Cancer Center, Kanagawa, Japan.. Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.. Department of Medicine, Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI, United States.. Department of Transplantation, Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, United States.. |
Issue Date: | 2022 | Date: | 2022 | Publication information: | Frontiers in Oncology 2022; 12: 963753 | URI: | https://ahro.austin.org.au/austinjspui/handle/1/30796 | DOI: | 10.3389/fonc.2022.963753 | Journal: | Frontiers in Oncology | PubMed URL: | 36033540 | ISSN: | 2234-943X | Type: | Journal Article | Subjects: | Biliary cancers chemotherapy gemcitabine survival therapeutic response |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.